SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193125-23-201812
Filing Date
2023-08-02
Accepted
2023-08-02 17:28:44
Documents
7

Document Format Files

Seq Description Document Type Size
1 PREC14A d447529dprec14a.htm PREC14A 619398
2 GRAPHIC g447529g05g07.jpg GRAPHIC 85245
3 GRAPHIC g447529g05g08.jpg GRAPHIC 83929
4 GRAPHIC g447529g08p01.jpg GRAPHIC 206638
5 GRAPHIC g447529g08p02.jpg GRAPHIC 137648
6 GRAPHIC g447529g19n78.jpg GRAPHIC 18085
7 GRAPHIC g447529g26k02.jpg GRAPHIC 30243
  Complete submission text file 0001193125-23-201812.txt   1392722
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filed by) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-38052 | Film No.: 231137149
SIC: 2834 Pharmaceutical Preparations